rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-3-22
|
pubmed:abstractText |
Results from the Superior Yield of the New Strategy of Enoxaparin, Revascularization, and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial showed that the low-molecular-weight heparin (LMWH) enoxaparin was non-inferior compared with unfractionated heparin (UFH) in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) managed invasively.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1932-8737
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright (c) 2009 Wiley Periodicals, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E49-55
|
pubmed:meshHeading |
pubmed-meshheading:20127904-Aged,
pubmed-meshheading:20127904-Anticoagulants,
pubmed-meshheading:20127904-Antihypertensive Agents,
pubmed-meshheading:20127904-Antithrombins,
pubmed-meshheading:20127904-Clinical Trials as Topic,
pubmed-meshheading:20127904-Cohort Studies,
pubmed-meshheading:20127904-Female,
pubmed-meshheading:20127904-Health Knowledge, Attitudes, Practice,
pubmed-meshheading:20127904-Heparin,
pubmed-meshheading:20127904-Heparin, Low-Molecular-Weight,
pubmed-meshheading:20127904-Humans,
pubmed-meshheading:20127904-Hypolipidemic Agents,
pubmed-meshheading:20127904-Male,
pubmed-meshheading:20127904-Medication Adherence,
pubmed-meshheading:20127904-Middle Aged,
pubmed-meshheading:20127904-Platelet Aggregation Inhibitors,
pubmed-meshheading:20127904-Registries,
pubmed-meshheading:20127904-Research Subjects,
pubmed-meshheading:20127904-Time Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Influence of clinical trial participation on subsequent antithrombin use.
|
pubmed:affiliation |
Duke Clinical Research Institute, Duke University Medical Center, 2400 Pratt Street, Durham, NC 27705, USA. bimal.shah@duke.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|